Cellebrite DI CLBT Estimates

NASDAQ CLBT
$11.44 -0.01 (-0.09%)
As of: Sep 8, 2026 · 10:57 AM EDT
Analyst Estimates

Cellebrite DI Ltd. Revenue Estimates

Periods 26
Next Period Q3 26
Consensus 152.12 M

Analysts expect Cellebrite DI Ltd. to report revenue of 152.12 M for Q3 26, against a range of 140.22 M to 164.02 M. The most recent reported quarter, Q2 26, came in at 131.14 M, a 7.2% beat against the 122.36 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 106.86 M109.05 M107.55 M113.28 M126.03 M128.82 M128.30 M131.14 M--------
High Estimate 114.77 M107.65 M116.84 M123.45 M137.06 M129.19 M140.70 M132.08 M164.02 M168.62 M149.19 M156.04 M181.35 M171.21 M165.04 M187.66 M
Low Estimate 96.12 M100.95 M96.66 M115.05 M125.27 M112.70 M121.47 M112.64 M140.22 M154.53 M128.76 M132.78 M168.37 M156.23 M153.92 M172.40 M
Consensus Estimate 105.45 M104.30 M106.75 M119.25 M131.16 M120.95 M131.08 M122.36 M152.12 M161.58 M138.98 M144.41 M174.86 M163.72 M159.48 M180.03 M
Analyst Estimates

Cellebrite DI Ltd. Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q3 26
Consensus 0.09

Analysts expect Cellebrite DI Ltd. to report earnings per share of 0.09 for Q3 26, against a range of 0.09 to 0.09. The most recent reported quarter, Q2 26, came in at 0.02, a 66.7% miss against the 0.06 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.990.080.070.080.080.080.040.02--------
High Estimate 0.070.070.050.090.110.100.050.060.090.120.060.060.210.340.03-0.02
Low Estimate 0.070.070.050.070.090.080.050.060.090.100.060.060.190.300.03-0.02
Consensus Estimate 0.070.070.050.080.100.090.050.060.090.110.060.060.200.320.03-0.02